References
- HG Boman. (1991). Antibacterial peptides: Key components needed in immunity. Cell 65:205–207.
- J Cho, and Y Kim. (2002). Sharks: A Potential Source of Antiangiogenic Factors and Tumor Treatments. Marine Biotechnol 4:521–525.
- R Stone. (1993). Deja vu guides the way to new antimicrobial steroid. Science 259:1125.
- M Zasloff. (1992). Curr Opin Immunol 4:3–7.
- M Zasloff. (1994). Antibacterial molecules from frogs, sharks and man. Phylogenet Perspect Immun Insect Host Def 31–41.
- SL Wehrli, KS Moore, H Roder, S Durell, and M Zasloff. (1993). Structure of the novel steroidal antibiotic squalamine determined by two-dimensional NMR spectroscopy. Steroids 58:370–378.
- PB Savage. (2002). Cationic steroid antibiotics. Curr Med Chem-Anti-Infective Agents 1:293–304.
- PB Savage. (2002). Design, synthesis and characterization of cationic peptide and steroid antibiotics. Eur J Org Chem 759–768.
- KS Moore, S Wehrli, H Roder, M Rogers, JN ForrestJr, D McCrimmon, and M Zasloff. (1993). Squalamine: An aminosterol antibiotic from the shark. Proc Natl Acad Sci USA 90:1354–1358.
- MN Rao, AE Shinnar, LA Noecker, TL Chao, B Feibush, B Snyder, I Sharkansky, A Sarkahian, X Zhang, SR Jones, WA Kinney, and M Zasloff. (2000). Aminosterols from the dogfish shark Squalus acanthias. J Nat Prod 63:631–635.
- JM Brunel, and Y Letourneux. (2003). Recent advances in the synthesis of spermine and spermidine analogs of the shark aminosterol squalamine. Eur J Org Chem 3897–3907.
- JM Brunel, C Salmi, C Loncle, N Vidal, and Y Letourneux. (2005). Squalamine: A polyvalent drug of the future. Curr Cancer Drug Targets 5:267–272.
- K Hamana, and S Matsuzaki. (1992). Polyamines as a chemotaxonomic marker in bacterial systematics. Crit Rev Microbiol 18:261–283.
- HM Wallace. (1998). Polyamines: Specific metabolic regulators or multifunctional polycations?. Biochem Soc Trans 26:569–571.
- HM Wallace. (2000). The physiological role of the polyamines. Eur J Clin Inv 30:1–3.
- HM Wallace. (2003). Polyamines and their role in human disease - an introduction. Biochem Soc Trans 31:354–355.
- FR Saunders, and HM Wallace. (2007). Polyamine metabolism and cancer prevention. Biochem Soc Trans 35:364–368.
- K Yasuda, C Ohmizo, and T Katsu. (2004). Mode of action of novel polyamines increasing the permeability of bacterial outer membrane. Int J of Antimicrob Agents 24:67–71.
- HS Kim, BS Choi, KC Kwon, SO Lee, HJ Kwak, and CH Lee. (2000). Synthesis and antimicrobial activity of squalamine analogue. Bioorg Med Chem 8:2059–2065.
- K Kikuchi, EM Bernard, A Sadownik, SL Regen, and D Armstrong. (1997). Antimicrobial activities of squalamine mimics. Antimicrob Agents Chemother 41:1433–1438.
- SR Jones, WA Kinney, X Zhang, LM Jones, and BS Selinsky. (1996). The synthesis and characterization of analogs of the antimicrobial compound squalamine: 6β-hydroxy-3-aminosterols synthesized from hyodeoxycholic acid. Steroids 61:565–571.
- A Sadownik, G Deng, V Janout, SL Regen, EM Bernard, K Kikuchi, and D Armstrong. (1995). Rapid Construction of a Squalamine Mimic. J Am Chem Soc 117:6138–6139.
- S Khabnadideh, CL Tan, SL Croft, H Kendrick, V Yardley, and IH Gilbert. (2000). Squalamine analogs as potential anti-trypanosomal and anti-leishmanial compounds. Bioorg Med Chem Lett 10:1237–1239.
- C Salmi, Y Letourneux, and JM Brunel. (2006). Efficient synthesis of various secondary amines through a titanium(IV) isopropoxide-mediated reductive amination of ketones. Lett Org Chem 3:396–401.
- C Salmi, Y Letourneux, and JM Brunel. (2006). Efficient diastereoselective titanium(IV) reductive amination of ketones. Lett Org Chem 3:384–389.
- National commitee for clinical laboratory standards. 1992. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A2. National commitee for clinical laboratory standards, Villanova, Pa..